These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2286795)
1. The use of hydralazine to manipulate tumour temperatures during hyperthermia. Dewhirst MW; Prescott DM; Clegg S; Samulski TV; Page RL; Thrall DE; Leopold K; Rosner G; Acker JC; Oleson JR Int J Hyperthermia; 1990; 6(6):971-83. PubMed ID: 2286795 [TBL] [Abstract][Full Text] [Related]
2. Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia. Poulson JM; Vujaskovic Z; Gaskin AA; Larue SM; Meyer RE; Prescott DM; Samulski TV; Thrall DE; Dewhirst MW Int J Hyperthermia; 2004 Aug; 20(5):477-89. PubMed ID: 15277021 [TBL] [Abstract][Full Text] [Related]
3. A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously. Thrall DE; Dewhirst MW; Page RL; Samulski TV; McLeod DA; Oleson JR Int J Hyperthermia; 1990; 6(2):305-17. PubMed ID: 2324571 [TBL] [Abstract][Full Text] [Related]
4. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. Gillette SM; Dewhirst MW; Gillette EL; Thrall DE; Page RL; Powers BE; Withrow SJ; Rosner G; Wong C; Sim DA Int J Hyperthermia; 1992; 8(3):309-20. PubMed ID: 1607736 [TBL] [Abstract][Full Text] [Related]
5. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. Voorhees WD; Babbs CF Eur J Cancer Clin Oncol; 1982 Oct; 18(10):1027-33. PubMed ID: 6891638 [TBL] [Abstract][Full Text] [Related]
6. Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy. Prescott DM; Charles HC; Sostman HD; Dodge RK; Thrall DE; Page RL; Tucker JA; Harrelson JM; Leopold KA; Oleson JR Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):415-23. PubMed ID: 8276656 [TBL] [Abstract][Full Text] [Related]
7. Results of a preliminary study of the potential of vasodilators for improving thermotherapy of deep-seated tumours [printed with original paging at end of 2(2); omitted from Int J Hyperthermia 1986 Jan-Mar;2(1)]. Nussbaum GH; Babbs CF; Mintun MA Int J Hyperthermia; 1986; 2(2):61-4. PubMed ID: 3794418 [TBL] [Abstract][Full Text] [Related]
8. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. Horsman MR; Christensen KL; Overgaard J Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180 [TBL] [Abstract][Full Text] [Related]
9. Use of the vasodilator sodium nitroprusside to increase tumour temperature during loco-regional hyperthermia with a capacitive ring applicator in a rat tumour model. Krossnes BK; Hornsleth SN Int J Hyperthermia; 2002; 18(4):292-306. PubMed ID: 12079585 [TBL] [Abstract][Full Text] [Related]
10. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Vujaskovic Z; Poulson JM; Gaskin AA; Thrall DE; Page RL; Charles HC; MacFall JR; Brizel DM; Meyer RE; Prescott DM; Samulski TV; Dewhirst MW Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):179-85. PubMed ID: 10656391 [TBL] [Abstract][Full Text] [Related]
11. Response of 145 spontaneous canine head and neck tumours to radiation versus radiation plus microwave hyperthermia: results of a randomized phase III clinical study. Frew DG; Dobson JM; Stenning SP; Bleehen NM Int J Hyperthermia; 1995; 11(2):217-30. PubMed ID: 7790736 [TBL] [Abstract][Full Text] [Related]
12. Microwave hyperthermia in the treatment of spontaneous canine tumours: an analysis of treatment parameters and tumour response. Thompson JM; Dhoodhat YA; Bleehen NM; Gorman NT Int J Hyperthermia; 1988; 4(4):383-99. PubMed ID: 3385227 [TBL] [Abstract][Full Text] [Related]
13. Hydralazine pharmacodynamics in the dog. Kittleson MD; Hamlin RL Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299 [TBL] [Abstract][Full Text] [Related]
14. From hydralazine to CGRP to man? Field SB; Burney IA; Needham S; Maxwell RJ; Griffiths JR Int J Hyperthermia; 1994; 10(3):451-5. PubMed ID: 7930813 [TBL] [Abstract][Full Text] [Related]
15. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low. Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380 [TBL] [Abstract][Full Text] [Related]
16. Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. Thrall DE; Rosner GL; Azuma C; Larue SM; Case BC; Samulski T; Dewhirst MW Int J Hyperthermia; 2000; 16(5):415-28. PubMed ID: 11001575 [TBL] [Abstract][Full Text] [Related]
17. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093 [TBL] [Abstract][Full Text] [Related]
18. Hydralazine at thermoradiotherapy: tumor size and blood flow effects. Kozin SV; Hasegawa T; Ha-Kawa SK; Akagi K; Tanaka Y Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):505-10. PubMed ID: 8005807 [TBL] [Abstract][Full Text] [Related]
19. Blood perfusion measurements in human tumours: evaluation of laser Doppler methods. Acker JC; Dewhirst MW; Honoré GM; Samulski TV; Tucker JA; Oleson JR Int J Hyperthermia; 1990; 6(2):287-304. PubMed ID: 2324570 [TBL] [Abstract][Full Text] [Related]
20. Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine: effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069. Cole S; Robbins L Radiother Oncol; 1989 Nov; 16(3):235-43. PubMed ID: 2587812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]